Independent experts on an advisory panel to the U.S. Food and Drug Administration on Tuesday voted against Daiichi Sankyo Co Ltd’s treatment for adults with a...
Radiology Partners announced Tuesday, May 14, that it has entered a new practice partnership with North Carolina-based Greensboro Radiology. Greensboro Radiology is the largest independent radiology...
EUSA Pharma (EUSA), a global biopharmaceutical company focused on oncology and rare disease, today announced the strengthening of its senior leadership team with the appointments of Carsten...
Private hospitals in Thailand will have to display the price of medicines so that consumers can make better-informed decisions prior to purchase, starting from this week....
Pneuma Respiratory, Inc., developer of a proprietary breath-activated digital inhaler (BDI), and Leads Biolabs Inc. announce an agreement granting Pneuma an exclusive license to develop Leads Biolabs’...
China Pharma Holdings, Inc. (NYSE American: CPHI) (“China Pharma,” the “Company” or “We”), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today...
The explosive new book, “Bottle of Lies: The Inside Story of the Generic Drug Boom,” was released today and, in response, top public health and policy...
A Japanese government panel approved Novartis’ cancer treatment Kymriah at a price of 33.5 million yen ($305,800) on Wednesday, marking the entry of so-called CAR-T therapy...
ElevateBio, a new company focused on the development of startup cell and gene therapy companies, launched with a $150 million Series A financing round. The new incubator, located...
Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, is announcing at Digestive Disease Week 2019 the launch and 510(k) clearance of the ESG-150 Electrosurgery Generator (ESG-150). Electrosurgical...
Novartis on Monday said claims of price fixing against its Sandoz generics unit amid a U.S. probe of 20 drugmakers are without merit, with the Swiss...
GRAIL, a healthcare company with a mission to detect cancer early, has secured the Breakthrough Device designation from the US Food and Drug Administration (FDA), for...
Encision Inc. (PK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous stray electrosurgical burns in minimally invasive surgery, today announced...
The Swedish healthcare region Skåne has gone live with a digital pathology solution from the international medical imaging IT and cybersecurity company Sectra (STO: SECT B). The solution...
Eli Lilly snagged regulatory approval for Cyramza as a single agent for the second-line treatment of patients with hepatocellular carcinoma (HCC) who have an alpha-fetoprotein (AFP) and have...
Copyright © 2024 Medical Buyer maintained by Fullstack development